Swiss National Bank’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.3M Buy
45,840
+1,360
+3% +$628K 0.01% 630
2026
Q1
$21.4M Buy
44,480
+160
+0.4% +$81.9K 0.01% 639
2025
Q4
$24.9M Sell
44,320
-3,080
-6% -$1.75M 0.01% 591
2025
Q3
$24.4M Sell
47,400
-1,700
-3% -$742K 0.01% 585
2025
Q2
$15.4M Sell
49,100
-2,100
-4% -$630K 0.01% 719
2025
Q1
$15.6M Sell
51,200
-600
-1% -$202K 0.01% 691
2024
Q4
$17.2M Buy
51,800
+300
+0.6% +$102K 0.01% 692
2024
Q3
$17.2M Sell
51,500
-300
-0.6% -$114K 0.01% 690
2024
Q2
$21.3M Buy
51,800
+3,400
+7% +$1.35M 0.01% 621
2024
Q1
$19.6M Buy
48,400
+200
+0.4% +$70.3K 0.01% 650
2023
Q4
$14.8M Sell
48,200
-5,500
-10% -$1.48M 0.01% 709
2023
Q3
$13M Hold
53,700
0.01% 773
2023
Q2
$12.9M Hold
53,700
0.01% 782
2023
Q1
$10.1M Sell
53,700
-6,200
-10% -$1.28M 0.01% 859
2022
Q4
$12.7M Sell
59,900
-900
-1% -$180K 0.01% 799
2022
Q3
$9.56M Sell
60,800
-5,600
-8% -$894K 0.01% 900
2022
Q2
$9.94M Sell
66,400
-1,600
-2% -$232K 0.01% 926
2022
Q1
$11.1M Buy
68,000
+4,900
+8% +$808K 0.01% 962
2021
Q4
$13.7M Sell
63,100
-500
-0.8% -$105K 0.01% 844
2021
Q3
$12M Buy
63,600
+600
+1% +$109K 0.01% 903
2021
Q2
$11.1M Sell
63,000
-2,400
-4% -$414K 0.01% 958
2021
Q1
$10.7M Buy
65,400
+1,300
+2% +$199K 0.01% 965
2020
Q4
$8.92M Hold
64,100
0.01% 1001
2020
Q3
$7.16M Sell
64,100
-400
-0.6% -$46.3K 0.01% 974
2020
Q2
$6M Buy
64,500
+8,600
+15% +$732K 0.01% 1043
2020
Q1
$4.1M Buy
55,900
+1,200
+2% +$104K ﹤0.01% 1037
2019
Q4
$4.6M Buy
54,700
+800
+1% +$61.9K ﹤0.01% 1210
2019
Q3
$4.53M Buy
53,900
+800
+2% +$60.4K ﹤0.01% 1155
2019
Q2
$3.47M Buy
53,100
+4,400
+9% +$254K ﹤0.01% 1345
2019
Q1
$2.87M Buy
48,700
+1,500
+3% +$89.6K ﹤0.01% 1430
2018
Q4
$2.5M Sell
47,200
-1,600
-3% -$87.8K ﹤0.01% 1425
2018
Q3
$2.92M Buy
48,800
+32,600
+201% +$1.78M ﹤0.01% 1462
2018
Q2
$697K Hold
16,200
﹤0.01% 2346
2018
Q1
$566K Buy
16,200
+1,800
+13% +$65.8K ﹤0.01% 2334
2017
Q4
$522K Buy
14,400
+1,000
+7% +$35.1K ﹤0.01% 2397
2017
Q3
$427K Hold
13,400
﹤0.01% 2416
2017
Q2
$389K Hold
13,400
﹤0.01% 2473
2017
Q1
$400K Hold
13,400
﹤0.01% 2435
2016
Q4
$483K Buy
+13,400
New +$446K ﹤0.01% 2410

Other funds holding MEDP

Swiss National Bank's MEDP Position: Q2 2026 in Review

Swiss National Bank increased its Medpace (MEDP) stake by 3.1% in Q2 2026, buying an estimated $628K and bringing the position to 45,840 shares worth $24.3M. The position accounts for 0.01% of the portfolio, ranked #630.

Swiss National Bank first reported a position in MEDP in Q4 2016 and has held it in 39 quarters since. The position peaked at $24.9M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Swiss National Bank held 45,840 shares of Medpace worth $24.3M as of Q2 2026.
  • Swiss National Bank bought 1,360 Medpace shares in Q2 2026, an estimated $628K.
  • Medpace made up 0.01% of Swiss National Bank's portfolio in Q2 2026, its #630 holding.
  • Swiss National Bank first reported a position in Medpace in Q4 2016 and has held it in 39 quarters since.
  • Swiss National Bank's Medpace position peaked at $24.9M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.